{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:40:46Z","timestamp":1792737646123,"version":"4.5.0"},"reference-count":74,"publisher":"SAGE Publications","issue":"1-2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Campbell Systematic Reviews: Better Evidence for a Better World"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Amphetamine-type stimulants (ATS) refer to a group of synthetic stimulants including amphetamine, methamphetamine, 3,4-methylenedioxy-methamphetamine (MDMA) and related substances. ATS are highly addictive and prolonged use may result in a series of mental and physical symptoms including anxiety, confusion, insomnia, mood disturbances, cognitive impairments, paranoia, hallucinations and delusion.<\/jats:p>\n                    <jats:p>Currently there is no widely accepted treatment for ATS-use disorder. However, cognitive-behavioural treatment (CBT) is the first-choice treatment. The effectiveness of CBT for other substance-use disorders (e.g. alcohol-, opioid- and cocaine-use disorders) has been well documented and as such this basic treatment approach has been applied to the ATS-use disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the efficacy of cognitive-behavioural treatment for people with ATS-use disorder for reducing ATS use compared to other types of psychotherapy, pharmacotherapy, 12-step facilitation, no intervention or treatment as usual.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Search methods<\/jats:title>\n                    <jats:p>We identified randomised controlled trials (RCT) and quasi-RCTs comparing CBT for ATS-use disorders with other types of psychotherapy, pharmacotherapy, 12 step facilitation or no intervention. We searched the Cochrane Drugs and Alcohol Group Specialised Register, Cochrane Central Register of Controlled Trials, MEDLINE via PubMed, Embase and five other databases up to July 2018. In addition, we examined reference lists of eligible studies and other systematic reviews. We contacted experts in the field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Selection criteria<\/jats:title>\n                    <jats:p>Eligibility criteria consisted of RCTs and quasi-RCTs comparing CBT versus other types of interventions with adult ATS users (aged 18 years or older) diagnosed by any explicit diagnostic system. Primary outcomes included abstinence rate and other indicators of drug-using behaviours.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data collection and analysis<\/jats:title>\n                    <jats:p>We used standard methodological procedures expected by Cochrane.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main results<\/jats:title>\n                    <jats:p>Only two studies met the eligibility criteria. Both studies were at low risk of selection bias and reporting bias. In one study, almost half of participants in the intervention group dropped out and this study was at high risk of attrition bias. The studies compared a single session of brief CBT or a web-based CBT to a waiting-list control (total sample size across studies of 129). Results were mixed across the studies. For the single-session brief CBT study, two out of five measures of drug use produced significant results, percentage of abstinent days in 90 days (odds ratio (OR) 0.22, 95% confidence interval (CI) 0.02 to 2.11) and dependence symptoms (standardised mean difference (SMD) \u20130.59, 95% CI\u20131.16 to\u20130.02). Little confidence could be placed in the results from this study give the small sample size (25 participants per group) and corresponding large CIs around the observed effects. For the web-based CBT, there was no significant difference across different outcomes. Neither study reported adverse effects. The meta-analytic mean across these two trials for drug use was not significant (SMD \u20130.28, 95% CI\u20130.69 to 0.14). In summary, overall quality of evidence was low and there was insufficient evidence to conclude that CBT is effective, or ineffective, at treating ATS use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Authors' conclusions<\/jats:title>\n                    <jats:p>Currently, there is not enough evidence to establish the efficacy of CBT for ATS-use disorders because of a paucity of high-quality research in this area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cl2.1026","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T07:58:56Z","timestamp":1566892736000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders"],"prefix":"10.1177","volume":"15","author":[{"given":"Takayuki","family":"Harada","sequence":"first","affiliation":[{"name":"Department of Psychology, Mejiro University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tsutomi","sequence":"additional","affiliation":[{"name":"Faculty of International Relations, University of Shizuoka, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Health Policy, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B","family":"Wilson","sequence":"additional","affiliation":[{"name":"Criminology, Law and Society, George Mason University, Fairfax, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"e_1_3_5_2_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/14659890903075074"},{"key":"e_1_3_5_2_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-12-67"},{"issue":"1","key":"e_1_3_5_2_4_1","article-title":"A web-based intervention for users of amphetamine-type stimulants: 3-month outcomes of a randomized controlled trial","volume":"1","author":"Tait R. J.","year":"2014","unstructured":"Tait R. J., McKetin R., Kay-Lambkin F., Carron-Arthur B., Bennett A., Christensen H., et al. (2014). A web-based intervention for users of amphetamine-type stimulants: 3-month outcomes of a randomized controlled trial. Journal of Medical Internet Research Mental Health, 1(1), e1. https:\/\/doi.org\/10.2196\/mental.3278[CRSREF: 9775994.","journal-title":"Journal of Medical Internet Research Mental Health"},{"key":"e_1_3_5_2_5_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.3778"},{"key":"e_1_3_5_2_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.96912797.x"},{"key":"e_1_3_5_2_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01002.x"},{"key":"e_1_3_5_2_8_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.188.5.439"},{"key":"e_1_3_5_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2009.03.007"},{"key":"e_1_3_5_2_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.354"},{"key":"e_1_3_5_2_11_1","doi-asserted-by":"publisher","DOI":"10.1081\/ADA-120020519"},{"key":"e_1_3_5_2_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12671-016-0586-9"},{"key":"e_1_3_5_2_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2000.10400222"},{"key":"e_1_3_5_2_14_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.15.3.301"},{"key":"e_1_3_5_2_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2010.00203.x"},{"issue":"3","key":"e_1_3_5_2_16_1","first-page":"S38","article-title":"The influence of depression on treatment for methamphetamine use","volume":"195","author":"Kay-Lambkin F. J.","year":"2011","unstructured":"Kay-Lambkin F. J., Baker A. L., Lee N. M., Jenner L., Lewin T. J. (2011). The influence of depression on treatment for methamphetamine use. Medical Journal of Australia, 195(3), S38\u2013S43[CRSREF: 9776017].","journal-title":"Medical Journal of Australia"},{"key":"e_1_3_5_2_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2013.847995"},{"key":"e_1_3_5_2_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12608"},{"key":"e_1_3_5_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.04.005"},{"key":"e_1_3_5_2_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02874551"},{"key":"e_1_3_5_2_21_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2012.11121831"},{"key":"e_1_3_5_2_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/1557988315590837"},{"key":"e_1_3_5_2_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jti029"},{"key":"e_1_3_5_2_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.2.201"},{"key":"e_1_3_5_2_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.10.1148"},{"key":"e_1_3_5_2_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00707.x"},{"key":"e_1_3_5_2_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01312.x"},{"key":"e_1_3_5_2_28_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1993"},{"key":"e_1_3_5_2_29_1","doi-asserted-by":"publisher","DOI":"10.1081\/ADA-37562"},{"key":"e_1_3_5_2_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2013.12068.x"},{"key":"e_1_3_5_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.02.015"},{"key":"e_1_3_5_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.10.004"},{"key":"e_1_3_5_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.03.010"},{"key":"e_1_3_5_2_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/j.1440-1614.1999.00621.x"},{"key":"e_1_3_5_2_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897071003641578"},{"issue":"8","key":"e_1_3_5_2_36_1","first-page":"1075","article-title":"Efficacy of group motivational interviewing plus brief cognitive behavior therapy for relapse in amphetamine users with co-occurring psychological problems at Southern Psychiatric Hospital in Thailand","volume":"95","author":"Suvanchot K. S.","year":"2012","unstructured":"Suvanchot K. S., Somrongthong R., Phukhao D. (2012). Efficacy of group motivational interviewing plus brief cognitive behavior therapy for relapse in amphetamine users with co-occurring psychological problems at Southern Psychiatric Hospital in Thailand. Journal of Medical Association of Thailand, 95(8), 1075\u20131080[CRSREF: 9776057].","journal-title":"Journal of Medical Association of Thailand"},{"key":"e_1_3_5_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2013.08.018"},{"key":"e_1_3_5_2_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.nmd.0000144699.80765.7f"},{"key":"e_1_3_5_2_39_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_5_2_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1490"},{"key":"e_1_3_5_2_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/0959523031000154472"},{"key":"e_1_3_5_2_42_1","doi-asserted-by":"publisher","DOI":"10.1139\/jpn.0635"},{"key":"e_1_3_5_2_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01423.x"},{"key":"e_1_3_5_2_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.95913355.x"},{"key":"e_1_3_5_2_45_1","doi-asserted-by":"publisher","DOI":"10.3109\/14659891.2011.592900"},{"key":"e_1_3_5_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60742-8"},{"key":"e_1_3_5_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2008.12.022"},{"key":"e_1_3_5_2_48_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00195.x"},{"key":"e_1_3_5_2_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2000.10400225"},{"key":"e_1_3_5_2_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-6723.2008.01114.x"},{"issue":"6","key":"e_1_3_5_2_51_1","first-page":"298","article-title":"The randomized controlled trial of the prison-based Japanese Matrix Program (J-MAT) for methamphetamine abusers","volume":"47","author":"Harada T.","year":"2010","unstructured":"Harada T. (2010). The randomized controlled trial of the prison-based Japanese Matrix Program (J-MAT) for methamphetamine abusers. Nihon Arukoru Yakubutsu Igakkai Zasshi [Japanese Journal of Alcohol Studies & Drug Dependence], 47(6), 298\u2013307[PubMed: 23461218].","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi [Japanese Journal of Alcohol Studies & Drug Dependence]"},{"key":"e_1_3_5_2_52_1","unstructured":"Higgins JP Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011. Available from handbook.cochrane.org."},{"key":"e_1_3_5_2_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03076.x"},{"key":"e_1_3_5_2_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.03792.x"},{"key":"e_1_3_5_2_55_1","article-title":"Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders","volume":"3","author":"Knapp W. P.","year":"2008","unstructured":"Knapp W. P., Soares B., Farrell M., Silva de Lima M. (2008). Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database of Systematic Reviews, Issue 3, https:\/\/doi.org\/10.1002\/14651858.CD003023Art. No.: CD003023.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_3_5_2_56_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230801919494"},{"key":"e_1_3_5_2_57_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Lefebvre C.","year":"2011","unstructured":"Lefebvre C., Manheimer E., Glanville J. (2011). Chapter 6: Searching for studies. In Higgins J. P., Green S. (Eds.), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from. handbook.cochrane.org."},{"key":"e_1_3_5_2_58_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.71.1.118"},{"key":"e_1_3_5_2_59_1","first-page":"1","volume-title":"Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors","author":"Marlatt G. A.","year":"2005","unstructured":"Marlatt G. A., Witkiewits, K. (2005). Relapse prevention for alcohol and drug problems, Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors (2nd edition, pp. 1\u201344). New York (NY): Guilford Press.","edition":"2"},{"key":"e_1_3_5_2_60_1","article-title":"Psychosocial interventions for psychostimulant misuse","volume":"9","author":"Minozzi S.","year":"2016","unstructured":"Minozzi S., Saulle R., De Crescenzo F., Amato L. (2016). Psychosocial interventions for psychostimulant misuse. Cochrane Database of Systematic Reviews, Issue 9, https:\/\/doi.org\/10.1002\/14651858.CD011866Art. No.: CD011866.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_3_5_2_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/10673220216223"},{"key":"e_1_3_5_2_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000545"},{"key":"e_1_3_5_2_63_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.951014753.x"},{"key":"e_1_3_5_2_64_1","unstructured":"National Institute on Drug Abuse. NIDA research report series: MDMA (Ecstasy) abuse 2006. www.drugabuse.gov\/sites\/default\/files\/rrmdma_0.pdf (accessed prior to 27 November 2018)."},{"key":"e_1_3_5_2_65_1","doi-asserted-by":"publisher","DOI":"10.1159\/000026666"},{"key":"e_1_3_5_2_66_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.9.817"},{"key":"e_1_3_5_2_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2011.11.029"},{"key":"e_1_3_5_2_68_1","unstructured":"Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen: The Nordic Cochrane Centre The Cochrane Collaboration 2011."},{"key":"e_1_3_5_2_69_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta13060"},{"key":"e_1_3_5_2_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60743-X"},{"key":"e_1_3_5_2_71_1","first-page":"1","volume-title":"Introduction to Addictive Behaviors","author":"Thombs D. L.","year":"2005","unstructured":"Thombs D. L. (2005). The multiple conceptions of addictive behavior and professional practice today, Introduction to Addictive Behaviors. (3rd edition, pp. 1\u201317). New York (NY): Guilford Press.","edition":"3"},{"key":"e_1_3_5_2_72_1","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.18.1.19273"},{"key":"e_1_3_5_2_73_1","doi-asserted-by":"publisher","DOI":"10.18356\/94bbf1f4-en"},{"key":"e_1_3_5_2_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e32832a3b44"},{"key":"e_1_3_5_2_75_1","volume-title":"International Statistical Classification of Diseases and Related Health Problems","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. (2004). International Statistical Classification of Diseases and Related Health Problems (1, 2nd edition.). Geneva: WHO.","edition":"2"}],"container-title":["Campbell Systematic Reviews: Better Evidence for a Better World"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcl2.1026","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1002\/cl2.1026","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1002\/cl2.1026","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1002\/cl2.1026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:24:31Z","timestamp":1792736671000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1002\/cl2.1026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":74,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1002\/cl2.1026"],"URL":"https:\/\/doi.org\/10.1002\/cl2.1026","relation":{},"ISSN":["1891-1803","1891-1803"],"issn-type":[{"value":"1891-1803","type":"print"},{"value":"1891-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]},"article-number":"cl2.1026"}}